What is Pure Diagnostic?
Pure Diagnostic operates as a CLIA-certified laboratory, offering a comprehensive suite of diagnostic testing services. Their offerings include genetic testing, toxicology analysis, and COVID-19 testing, primarily serving healthcare professionals such as pain management clinics, family practices, and addiction specialists. The laboratory provides essential tools for monitoring medication compliance and identifying the presence of unprescribed medications, thereby supporting clinicians in delivering optimal patient care. Pure Diagnostic distinguishes itself through rapid sample turnaround times and reliable lab results, complemented by a focus on personalized service and an efficient web-based ordering system, aiming to streamline healthcare delivery.
How much funding has Pure Diagnostic raised?
Pure Diagnostic has raised a total of $169K across 1 funding round:
Debt
$169K
Debt (2021): $169K with participation from PPP
Key Investors in Pure Diagnostic
PPP
Public-Private Partnership
What's next for Pure Diagnostic?
With a substantial large-scale late-stage funding context, Pure Diagnostic is poised for significant expansion and operational enhancement. This strategic backing is likely to fuel advancements in their testing methodologies, broaden their service offerings, and potentially expand their market reach. The company's focus on efficiency and data-driven insights suggests a future where they continue to innovate in diagnostic technology, further solidifying their role as a key partner for healthcare providers seeking accurate and timely patient monitoring solutions.
See full Pure Diagnostic company page
